Labetalol disposition interferes with fluorimetric dosage of catecholamines: in vitro and in vivo trials with enzymatic inhibitors.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology*; D005470:Fluorometry; D066298:In Vitro Techniques; D007741:Labetalol / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D011335:Proadifen / Q000494:pharmacology; D051381:Rats
D002395:Catecholamines; D004791:Enzyme Inhibitors; D004983:Ethanolamines; D011335:Proadifen; D007741:Labetalol